Publications in collaboration with researchers from Hospital Universitario Virgen de las Nieves (29)

2024

  1. ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-related cancer

  2. Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466

  3. Glucose metabolism outcomes after pituitary surgery in patients with acromegaly

    Pituitary, Vol. 27, Núm. 5, pp. 497-506

  4. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-Related Cancer, Vol. 31, Núm. 7

  5. Ultrasound Cut-Off Values for Rectus Femoris for Detecting Sarcopenia in Patients with Nutritional Risk

    Nutrients, Vol. 16, Núm. 11

2023

  1. Comprehensive approach to people with type 2 diabetes. Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 95-102

  2. Descriptive study of a clinical and educational telemedicine intervention in patients with diabetes receiving glargine 300 U/ml (Toujeo) in Spain: results of the T-Coach programme

    Drugs in Context, Vol. 12, pp. 1-11

2022

  1. A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort

    European Journal of Preventive Cardiology, Vol. 29, Núm. 5, pp. 795-801

  2. Registro del Grupo NADYA-SENPE de Nutrición Enteral Domiciliaria en España: años 2018 y 2019

    Nutricion hospitalaria, Vol. 39, Núm. 1, pp. 223-229

2021

  1. Executive summary: Position document: Evaluation and management of hypoglycemia in the patient with diabetes mellitus 2020. Diabetes Mellitus Working Group of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 4, pp. 270-276

2020

  1. Association of hypertension with all-cause mortality among hospitalized patients with COVID-19

    Journal of Clinical Medicine, Vol. 9, Núm. 10, pp. 1-12

  2. Effectiveness of lanreotide autogel 120 mg at extended dosing intervals for acromegaly

    Endocrine, Vol. 70, Núm. 3, pp. 575-583

  3. Home and Ambulatory Artificial Nutrition (NADYA) group report. Home parenteral nutrition in Spain, 2018

    Nutricion Hospitalaria, Vol. 37, Núm. 2, pp. 403-407

  4. Incidence of cardiovascular events and changes in the estimated risk and treatment of familial hypercholesterolemia: the SAFEHEART registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 10, pp. 828-834

2019

  1. ACROSTART: A retrospective study of the time to achieve hormonal control with lanreotide Autogel treatment in Spanish patients with acromegaly

    Endocrinologia, Diabetes y Nutricion, Vol. 66, Núm. 5, pp. 320-329

  2. Document on a comprehensive approach to type 2 diabetes mellitus

    Endocrinologia, Diabetes y Nutricion, Vol. 66, Núm. 7, pp. 443-458

  3. Effect of Telephone-Delivered Interventions on Glycemic Control in Type 2 Diabetes Treated with Glargine Insulin

    Telemedicine and e-Health, Vol. 25, Núm. 6, pp. 471-476

  4. Spanish home enteral nutrition registry of the year 2016 and 2017 from the NADYA-SENPE Group

    Nutricion Hospitalaria, Vol. 36, Núm. 1, pp. 233-237

2018

  1. Home and ambulatory artificial nutrition (NADYA) report. home parenteral nutrition in Spain, 2017

    Nutricion Hospitalaria, Vol. 35, Núm. 6, pp. 1491-1496

2017

  1. Nutrición parenteral domiciliaria en españa 2016; informe del grupo de nutrición artificial domiciliaria y ambulatoria nadya

    Nutricion Hospitalaria, Vol. 34, Núm. 6, pp. 1497-1501